Cleared Traditional

K913434 - VENTREX COATED TUBE INTACT PTH
(FDA 510(k) Clearance)

Oct 1991
Decision
85d
Days
Class 2
Risk

K913434 is an FDA 510(k) clearance for the VENTREX COATED TUBE INTACT PTH. This device is classified as a Radioimmunoassay, Parathyroid Hormone (Class II - Special Controls, product code CEW).

Submitted by Ventrex Laboratories, Inc. (Portland, US). The FDA issued a Cleared decision on October 25, 1991, 85 days after receiving the submission on August 1, 1991.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1545.

Submission Details

510(k) Number K913434 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 1991
Decision Date October 25, 1991
Days to Decision 85 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement

Device Classification

Product Code CEW — Radioimmunoassay, Parathyroid Hormone
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.1545

Similar Devices — CEW Radioimmunoassay, Parathyroid Hormone

All 85
Elecsys PTH , Elecsys PTH STAT
K231927 · Roche Diagnostics · Mar 2024
Access Intact PTH
K232791 · Beckman Coulter, Inc. · Mar 2024
VITROS Immunodiagnostic Products Intact PTH II Reagent Pack
K221197 · Ortho-Clinical Diagnostics · Sep 2023
Lumipulse G whole PTH
K190702 · Fujirebio Diagnostics,Inc. · Aug 2019
ADVIA Centaur Intact Parathyroid Hormone (PTH) Assay
K163658 · Siemens Healthcare Diagnostics, Inc. · May 2017
IDS-iSYS Intact PTHN
K161158 · Immunodiagnostic Systems , Ltd. · Jan 2017